Peramivir Market Strategies, Top Players, Growth, Analysis, and Forecast by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Peramivir Market covers analysis By Type (Solution, Solid); Application (Influenza A Treatment, Influenza B Treatment), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Nov 2025
  • Report Code : TIPRE00014944
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150
Page Updated: Jan 2025

The Peramivir Market is expected to register a CAGR of 5% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The Peramivir Market report is segmented by type into Solution and Solid. The application segment includes Influenza A Treatment and Influenza B Treatment. The market evaluation is presented in US$ for the above segmental analysis. The global analysis is broken down at the regional level and major countries. The market evaluation is presented in US$ for the above segmental analysis.

Purpose of the Report

The report Peramivir Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Peramivir Market Segmentation

Type

  • Solution
  • Solid

Application

  • Influenza A Treatment
  • Influenza B Treatment

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Peramivir Market: Strategic Insights

peramivir-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Peramivir Market Growth Drivers

  • Growing Trend of Influenza Seasonality: It has fairly established the effectiveness of this drug in curing influenza as well as more severe ones. As such, the number of the geriatric population susceptible to influenza resulting in serious infections will create more market demand.
  • Advancements in Healthcare Infrastructure and Awareness: Improvements in healthcare infrastructures and increasing awareness towards preventing and treating influenza have created momentum in the market.
  • Efficacy in Treating Severe Influenza Cases:
    Peramivir's ability to provide rapid relief through intravenous administration makes it a preferred option for hospitalized patients with severe influenza. Research on peramivir is under way for it to explore further antiviral use in general; therefore, the market of this medicine is most probably to grow constantly in the short-term period.

Peramivir Market Future Trends

  • Pandemic Preparedness: As the world is gradually aware of the potential for pandemics in the future, it is expected that more antiviral medications with higher efficacy than peramivir will be needed.
  • R&D Advancements in Peramivir: More R&D work is going into peramivir in formulating and delivery technology for better efficacy and better patient compliance.
  • Prophylactic Use of Peramivir: More scope of market growth can also be realized by considering peramivir as a prophylactic agent.

Peramivir Market Opportunities

  • Rising Incidence of Influenza Among Vulnerable Populations: The incidence of influenza is rapidly rising among the elderly and immunocompromised patients, and, thus, there is significant demand for effective antiviral treatments.
  • Prophylactic Use in High-Risk Settings: Another area with a huge market potential relates to the prophylactic use of peramivir, especially in high-risk settings like hospitals and nursing homes.
  • Research and Development in Formulation and Combination Therapies: More research and development work into enhancing the formulation, delivery, and combination therapies with other antiviral drugs could open up more applications for peramivir.

Peramivir Market Regional Insights

The regional trends and factors influencing the Peramivir Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Peramivir Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Peramivir Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 5%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Type
  • Solution
  • Solid
By Application
  • Influenza A Treatment
  • Influenza B Treatment
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Green Cross Pharma
  • Shionogi Co.
  • Neopharm
  • Moksha8 Pharma
  • NT Pharma
  • Merck
  • Hikma Pharmaceuticals
  • Hunan Nucien Pharmaceutical Co., Ltd.
  • SCOLR Pharma

Peramivir Market Players Density: Understanding Its Impact on Business Dynamics

The Peramivir Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.


peramivir-market-cagr

  • Get the Peramivir Market top key players overview

Key Selling Points

  • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Peramivir Market, providing a holistic landscape.
  • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Peramivir Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

1

Which are the leading players operating in the Peramivir Market?

The leading players of the market are: Green Cross Pharma, Shionogi Co., Neopharm, Moksha8 Pharma, NT Pharma, Merck, Hikma Pharmaceuticals, Hunan Nucien Pharmaceutical Co., Ltd., SCOLR Pharma, BioCryst Pharmaceuticals, Inc.
2

What are the deliverable formats of the Peramivir Market report?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
3

What are the options available for the customization of this report? 

Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
4

What are the future trends of the Peramivir Market?

The future of the peramivir market is bright, with several emerging trends. One of the most important trends is the increasing focus on pandemic preparedness. As the world develops an increased awareness of the possibility for future pandemics, more demand for effective antiviral drugs such as peramivir will certainly be seen. Furthermore, present research and development is continuing to work on formulating and delivering peramivir in a better fashion, which may bring a better response and adherence rate in patients. In addition, the prophylactic potential of peramivir is also under scrutiny, which will create some more opportunities for growth. However, long-term trend of the peramivir market may be affected by challenges such as the emergence of drug-resistant influenza strains and development of new antiviral agents.
5

What is the expected CAGR of the Peramivir Market?

Peramivir Market is expected to grow at a CAGR of 5% between 2023-2031
6

What are the driving factors impacting the Peramivir Market?

Several factors drive the peramivir market. Primarily, the increasing number of influenza cases, more significantly during seasonal outbreaks, forms a major driver. Since the drug is effective for severe cases of influenza, its importance in treatment cannot be denied. Moreover, with the increase in geriatric population, which tends to be more vulnerable to such severe infections, drives demand in the market even more. In addition, the development of healthcare infrastructure and the awareness of prevention and treatment of influenza are factors that are driving the market forward. As research continues to explore the potential of peramivir in broader antiviral applications, the market is expected to see continued growth in the years ahead.
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Our Clients
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Email: sales@theinsightpartners.com
Chat with us
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
ISO Certified Logo